Loading...

Zuellig Pharma invests in first innovation centre in Singapore

Image

05-Apr-17 Singapore based Zuellig Pharma has launched Zuellig Health Solutions innovation centre, in Singapore and plans to invest over USD35 mn in the next five years. On why it chose Singapore for its new venture, CEO John Davison said: "We see many of our clients in the pharmaceutical and consumer health sector (such as) GlaxoSmithKline and AstraZeneca here in Singapore." [image: Zuellig Pharma]

Read More

Ericsson eyes Healthcare IoT in China with China Mobile, AstraZeneca

Image

27-Mar-17 Ericsson has partnered with China Mobile and AstraZeneca to connect healthcare equipment using NB-IoT technology. China Mobile’s Jiangsu branch and Ericsson will work together to trial new applications using cellular IoT technologies like NB-IoT and provide network terminal management to support equipment management. Additionally, AstraZeneca is also working with the Wuxi government to open a China Commercial Innovation Center. [image: Wireless Week / Ericsson].

Read More

Chinese pharma companies are quietly catching up

Image

31-Mar-17 Without much press or international recognition, Chinese companies have been making good progress enhancing their pharmaceutical and healthcare prowess. For example, in the past few years, 50+ Chinese pharmaceutical companies have entered or completed phase I and phase II clinical trials, while 10+ companies have completed phase III trials. [image: China Money Network

Read More

Thai hospital Siriraj set to introduce eight robots

Image

16-Mar-17 Siriraj Hospital in Bangkok, Thailand plans to introduce robots into the dispensing process at its pharmacies to improve accuracy in preparing patients' prescriptions, increasing patient safety, and speeding up the hospital's pharmacy services. Currently the hospital handles more than 2 mn lists of medicine per year for patients and is targeting zero errors after the robots are introduced. [image: Bangkok Post]

Read More

J&J CEO is optimistic about China's healthcare market

Image

14-Mar-17 Alex Gorsky, CEO of Johnson & Johnson said: "We believe that the macro trends - a large population, urbanisation, growing middle class, demand for healthier lifestyles and care choices - remain favourable for... China's healthcare industry. J&J has a legacy of translating technological innovation and medical science breakthroughs into industrial outputs that address the needs of patients and consumers." [image: China Daily]

Read More
Share